Please login to the form below

Not currently logged in
Email:
Password:

Shire and TAP in joint sales drive

Specialty biopharmaceuticals company Shire announced on March 26 a joint sales agreement to promote its drug Lialda (mesalamine) in the US
Specialty biopharmaceuticals company Shire announced on March 26 a joint sales agreement to promote its drug Lialda (mesalamine) in the US.

The three-year agreement has been made with TAP Pharmaceutical Products based in Philadelphia in the US to increase sales of Lialda.

Lialda has been developed for use as a once daily oral formulation indicated for the induction of remission in patients with active mild to moderate ulcerative colitis.

Mike Yasick, senior vice president of Shire's gastrointestinal business unit, said: "Aligning with TAP, one of the most successful and well-respected GI sales organisations in the industry, is a tremendous benefit for Shire as it will quadruple the Lialda sales force across the United States."

"Shire's GI team has made Lialda the fastest growing brand of mesalamine and with his collaboration we will bolster the frequency of sales calls to our existing base of specialist physicians," he added.

Tim Rudolphi, vice president of TAP's gastroenterology marketing franchise, said: "This connection with Shire is a natural fit for our sales force, and is a win for all involved, especially the patient population who may benefit most."

27th March 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics